Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 25, 2014
Edoxaban transport via P-glycoprotein is a key factor for the drug's disposition
Tsuyoshi Mikkaichi, Yasushi Yoshigae, Hiroshi Masumoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 26, 2026
Characterization of human intestinal organoid-derived monolayers under air-liquid interface culture for pharmacokinetics evaluation
Ilona Wehl, Kazuyoshi Michiba, Veronika Walser, et al.
Pharmaceutical Research
|
November 9, 2014
Evaluation of the usefulness of breast cancer resistance protein (BCRP) knockout mice and BCRP inhibitor-treated monkeys to estimate the clinical impact of BCRP modulation on the pharmacokinetics of BCRP substrates
Tsuyoshi Karibe, Rie Hagihara-Nakagomi, Koji Abe, et al.
ACS Medicinal Chemistry Letters
|
July 17, 2024
Optimization of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors, Leading to the Potent DS08701581
Toru Taniguchi, Isao Yasumatsu, Hiroaki Inagaki, et al.
Scientific Reports
|
November 2, 2021
Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system
Tomoki Imaoka, Weize Huang, Sara Shum, et al.
ACS Pharmacology & Translational Science
|
June 23, 2020
An Improved Vascularized, Dual-Channel Microphysiological System Facilitates Modeling of Proximal Tubular Solute Secretion
Alenka Chapron, Brian D Chapron, Dale W Hailey, et al.
Toxicology
|
September 9, 2020
Microphysiological system modeling of ochratoxin A-associated nephrotoxicity
Tomoki Imaoka, Jade Yang, Lu Wang, et al.
ACS Medicinal Chemistry Letters
|
May 18, 2019
Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity
Toru Taniguchi, Hiroaki Inagaki, Daichi Baba, et al.
Scientific Reports
|
December 2, 2024
Development of a novel gut microphysiological system that facilitates assessment of drug absorption kinetics in gut
Tomoki Imaoka, Reiko Onuki-Nagasaki, Hiroshi Kimura, et al.
Molecular Cancer Therapeutics
|
November 16, 2019
A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model
Yukino Machida, Makoto Nakagawa, Hironori Matsunaga, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 25, 2014
Edoxaban transport via P-glycoprotein is a key factor for the drug's disposition
Tsuyoshi Mikkaichi, Yasushi Yoshigae, Hiroshi Masumoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 26, 2026
Characterization of human intestinal organoid-derived monolayers under air-liquid interface culture for pharmacokinetics evaluation
Ilona Wehl, Kazuyoshi Michiba, Veronika Walser, et al.
Pharmaceutical Research
|
November 9, 2014
Evaluation of the usefulness of breast cancer resistance protein (BCRP) knockout mice and BCRP inhibitor-treated monkeys to estimate the clinical impact of BCRP modulation on the pharmacokinetics of BCRP substrates
Tsuyoshi Karibe, Rie Hagihara-Nakagomi, Koji Abe, et al.
ACS Medicinal Chemistry Letters
|
July 17, 2024
Optimization of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors, Leading to the Potent DS08701581
Toru Taniguchi, Isao Yasumatsu, Hiroaki Inagaki, et al.
Scientific Reports
|
November 2, 2021
Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system
Tomoki Imaoka, Weize Huang, Sara Shum, et al.
ACS Pharmacology & Translational Science
|
June 23, 2020
An Improved Vascularized, Dual-Channel Microphysiological System Facilitates Modeling of Proximal Tubular Solute Secretion
Alenka Chapron, Brian D Chapron, Dale W Hailey, et al.
Toxicology
|
September 9, 2020
Microphysiological system modeling of ochratoxin A-associated nephrotoxicity
Tomoki Imaoka, Jade Yang, Lu Wang, et al.
ACS Medicinal Chemistry Letters
|
May 18, 2019
Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity
Toru Taniguchi, Hiroaki Inagaki, Daichi Baba, et al.
Scientific Reports
|
December 2, 2024
Development of a novel gut microphysiological system that facilitates assessment of drug absorption kinetics in gut
Tomoki Imaoka, Reiko Onuki-Nagasaki, Hiroshi Kimura, et al.
Molecular Cancer Therapeutics
|
November 16, 2019
A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model
Yukino Machida, Makoto Nakagawa, Hironori Matsunaga, et al.
Page
of 2